About Nemus Pharmaceuticals Private Limited
Data last updated:
Nemus Pharmaceuticals Private Limited is a private limited company based in Khalapur, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 21 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2010PTC211145. Its GSTIN is 29AADCN4820D1ZO (Karnataka). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹4.6 Cr and a paid-up capital of ₹4.02 Cr. It is led by directors including Sridhar Kumar Shetty (Managing Director) and Satish Prabhakarshetty Shetty.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at P 482/3 Sunit Mahaganapati Rees, Khalapur, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.76 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹2.16 Cr (net margin -7.2%) and EBITDA of ₹4.76 Cr (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 14% over five years.
The company has about 175 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹16.21 Cr and satisfied charges of ₹23.06 Cr on record. Court records list 9 cases involving the company, including 1 filed by the company and 8 filed against it; 4 cases are pending. The company has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹3.28 Cr; the latest was in March 2020. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Mediwell Pharmacia Private Limited with revenue of ₹29.93 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 37 overdue payments to 18 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nemuspharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressP 482/3 Sunit Mahaganapati Rees, Khalapur, Maharashtra, India – 410206
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nemus Pharmaceuticals Private Limited
The main business activity of Nemus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nemus Pharmaceuticals Private Limited FY 2024 filings available
Nemus Pharmaceuticals Private Limited reported revenue of ₹29.76 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nemus Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 21% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nemus Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.76 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.16 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nemus Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nemus Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediwell Pharmacia Private Limited | ₹29.93 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Baddi, Himachal Pradesh, India |
| Steranco Healthcare Private Limited | ₹29.92 Cr (FY 2025) | •••• | •••• | 121.0% | •••• | Mumbai, Maharashtra, India |
| Goa Antibiotics and Pharmaceuticals Limited | ₹29.84 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Goa, India |
| Anekant Pharmaceuticals Private Limited | ₹29.83 Cr (FY 2021) | •••• | •••• | 54.0% | •••• | Delhi, India |
| Usan Pharmaceuticals Private Limited | ₹29.79 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Nemus Pharmaceuticals Private Limited this company | ₹29.76 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Khalapur, Maharashtra, India |
| Vrnda Pharma Private Limited | ₹29.73 Cr (FY 2025) | •••• | •••• | 164.0% | •••• | Mumbai, Maharashtra, India |
| Milton Generic Private Limited | ₹29.72 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Mumbai, Maharashtra, India |
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Delhi, India |
| Infugen Pharma Private Limited | ₹29.66 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Sangli, Maharashtra, India |
| Growmax Medicare Private Limited | ₹29.58 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Nemus Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited is audited by A.PRASHANTH RAI for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A.PRASHANTH RAI | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Prabhakarshetty Shetty Also directs: Sumukh Wellness Private Limited, Bricasa Builders and Developers LLP, Malpefresh Marine Export Private Limited and 1 more | Director | 31 Aug 2018 | 8 Years 1 Months | Current |
| Venkataraja Chekodu Also directs: Tranway21 Technologies Limited | Director | 27 Jul 2021 | 5 Years 2 Months | Current |
| Shashi Bhushan Shukla | Director | 27 Jul 2021 | 5 Years 2 Months | Current |
| Seenappa Prabhakar Madhukar Also directs: Sahyadri Chits Private Limited, Shimoga Associates Private Limited | Director | 06 Jul 2015 | 11 Years 3 Months | Current |
| Ravikumar Nuggimakki Srinivasa Also directs: Pinnacle Data Services Private Limited | Director | 12 Jul 2021 | 5 Years 3 Months | Current |
| Sridhar Kumar Shetty Also directs: Sumukh Wellness Private Limited | Managing Director | 27 Jul 2011 | 15 Years 2 Months | Current |
Ownership and Shareholding of Nemus Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nemus Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2023 | Hdfc Bank Limited | ₹36.83 Lakh | Open |
| 24 Aug 2023 | Hdfc Bank Limited | ₹15.36 Cr | Open |
| 10 Jul 2020 | Others | ₹30 Lakh | Open |
| 24 Feb 2020 | Others | ₹18 Lakh | Open |
| 05 Apr 2023 | Karnataka Bank Ltd. | ₹9,000 | Satisfied |
Total charge records: 18 View all charges
Deals & Funding of Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹3.28 Cr; the latest was in March 2020.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Funding round | ₹2.01 Cr | Investors: 4 individuals |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2015 | Rights issue | ₹50 Lakh | Investors: an individual |
| Dec 2012 | Funding round | ₹1.27 Cr | Investors: 4 individuals |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited has 9 court cases on record: 1 filed by Nemus Pharmaceuticals, 8 filed against it. 4 cases are pending and 5 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 2 |
| High courts | 4 | 4 | 2 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CRR) | Filed against the company by Hindustan Unilever Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Hindustan Unilever Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Hindustan Unilever Limited | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Hindustan Unilever Limited | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by an individual | Pending |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 37 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 18)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Yakshasri Agri Products Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited has a workforce of 175 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals Private Limited has 18 board changes on record since 2011: 8 appointments and 10 cessations. The latest: Rajaram Shetty ceased to be Additional Director on 29 Sep 2023.
43 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nemus Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nemus Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCN4820D1ZO | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nemus Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nemus Pharmaceuticals Private Limited
Nemus Pharmaceuticals is an active private limited company based in Khalapur, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 21 December 2010 (16+ years old) and is registered under CIN U24239MH2010PTC211145.
Nemus Pharmaceuticals reported revenue of ₹29.76 Cr for FY 2025 (up 21% YoY).
Nemus Pharmaceuticals has 7 current directors:
- Sridhar Kumar Shetty - Managing Director
- Satish Prabhakarshetty Shetty - Director
- Venkataraja Chekodu - Director
- Shashi Bhushan Shukla - Director
- Seenappa Prabhakar Madhukar - Director
- Ravikumar Nuggimakki Srinivasa - Director
- Rajaram Shetty - Director
Nemus Pharmaceuticals reported a net loss of ₹2.16 Cr (net margin -7.2%) and EBITDA of ₹4.76 Cr (EBITDA margin 16%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nemus Pharmaceuticals is 16% over three years and 14% over five years. In the latest year (FY 2025) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nemus Pharmaceuticals is 29AADCN4820D1ZO, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Nemus Pharmaceuticals is U24239MH2010PTC211145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nemus Pharmaceuticals has 9 court cases on record: 1 filed by the company and 8 filed against it. 4 are pending. Most are in the district courts.
Nemus Pharmaceuticals was incorporated on 21 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Nemus Pharmaceuticals has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹3.28 Cr; the latest was in March 2020.
The peers of Nemus Pharmaceuticals by revenue are Mediwell Pharmacia Private Limited, Steranco Healthcare Private Limited, Goa Antibiotics and Pharmaceuticals Limited, Anekant Pharmaceuticals Private Limited, Usan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Rajaram Shetty ceased to be Additional Director on 29 Sep 2023. Rajaram Shetty was appointed as Director on 07 Oct 2022. Ravikumar Nuggimakki Srinivasa ceased to be Additional Director on 30 Nov 2021. Nemus Pharmaceuticals has 18 board changes on record in total.